Impact of a Formulary Change and Implementation of a Legacy Medication Alternative in the Electronic Medical Record on Antibiotic Prescribing In Children
The Journal of Pediatric Pharmacology and Therapeutics · 2026-08 · 31 (4) · 509-515
DOI: 10.5863/jppt-25-00069 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, 2026-08. Verfasst von Hailey Kemp und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy (HK), University of Florida Health Shands Hospital, Gainesville, FL. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVE To assess prescribing patterns following an oral cephalosporin formulary change and the implementation of a legacy medication alternative in the electronic medical record to discourage prescribing cefdinir when de-escalating intravenous ceftriaxone to an enteral antibiotic in pediatric patients. METHODS This was a single-center, retrospective cohort study of hospitalized pediatric patients who received at least 1 dose of ceftriaxone de-escalated to an enteral antibiotic for the treatment of community-acquired pneumonia, upper respiratory tract infection, or urinary tract infection. Patients from a 6-month period post-formulary change were compared with a historical cohort from the same timeframe, 1 year prior. The primary outcome was the change in cefdinir prescribing. Secondary outcomes included the rate of optimal antibiotic de-escalation before and after the interventions, hospital length of stay, and hospital re-encounter rates. RESULTS A total of 134 patients were included. Cefdinir prescribing occurred in 44% and 34% (p = 0.287) of patients pre- and post-intervention, respectively. Optimal enteral antibiotic de-escalation occurred in 46 (62%) patients pre-intervention and 43 (72%) post-intervention (p = 0.245). Rates of optimal de-escalation were lowest for patients treated for urinary tract infection (< 60% in both cohorts), with cefdinir used in 48% of these cases. Hospital re-encounters occurred in 6 (8%) patients pre-intervention and 0 (0%) post-intervention (p = 0.035). Median length of stay was significantly reduced (p = 0.038) post-intervention, driven by a 1-day reduction in patients treated for community-acquired pneumonia (p = 0.013). CONCLUSIONS After the formulary changes involving cefdinir, there was no significant decrease in cefdinir use or in optimal de-escalation rates. There were significantly lower hospital re-encounters and shorter lengths of stay, though further studies are needed to validate these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy (HK), University of Florida Health Shands Hospital, Gainesville, FL.
- Department of Pharmacy (KBM), University of Florida Health Children's Hospital, Gainesville, FL.
- Department of Pharmacy Education and Practice (KBM), University of Florida College of Pharmacy, Gainesville, FL.
Zitieren
APA
Kemp, H., & Manasco, K. B. (2026). Impact of a Formulary Change and Implementation of a Legacy Medication Alternative in the Electronic Medical Record on Antibiotic Prescribing In Children. The Journal of Pediatric Pharmacology and Therapeutics, 31(4), 509-515. https://doi.org/10.5863/jppt-25-00069
Vancouver
Kemp H, Manasco KB. Impact of a Formulary Change and Implementation of a Legacy Medication Alternative in the Electronic Medical Record on Antibiotic Prescribing In Children. The Journal of Pediatric Pharmacology and Therapeutics. 2026;31(4):509-515. doi:10.5863/jppt-25-00069
BibTeX
@article{Kemp2026,
author = {Kemp, Hailey and Manasco, Kalen B},
title = {Impact of a Formulary Change and Implementation of a Legacy Medication Alternative in the Electronic Medical Record on Antibiotic Prescribing In Children},
journal = {The Journal of Pediatric Pharmacology and Therapeutics},
year = {2026},
volume = {31},
number = {4},
pages = {509--515},
doi = {10.5863/jppt-25-00069}
}
EUVIMED